Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicilon Founder Chen Chunlin: An Interview With PharmAsia News

This article was originally published in PharmAsia News

Executive Summary

PharmAsia News' China Bureau recently spoke with Chen Chunlin, founder of Shanghai-based Medicilon, about the advantages and disadvantages for Western companies seeking partnerships with Chinese firms to conduct preclinical research, and the growth of Medicilon since its founding in 2003. U.S.-based MPI Research and Medicilon recently entered a joint venture to establish a preclinical research center in Shanghai that meets U.S. FDA and other international regulatory standards (PharmAsia News, Jan. 2, 2008)

You may also be interested in...



Insider Analysis From BioForesight: Navigating the Life Sciences Silk Road Frontier

By Zhu Shen, Chief Executive Officer, BioForesight

Insider Analysis From BioForesight: Navigating the Life Sciences Silk Road Frontier

By Zhu Shen, Chief Executive Officer, BioForesight

China’s WuXi To Acquire U.S.-Based AppTec Laboratory Services

SHANGHAI - WuXi PharmaTech will acquire U.S.-based AppTec Laboratory Services, the Chinese pharma outsourcing company announced Jan. 3

UsernamePublicRestriction

Register

LL1132440

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel